PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-148

  1. 339 Posts.
    lightbulb Created with Sketch. 129
    Would be interested to see the coppo report today if anyone has access to it.

    Also i'm sure the valuations will be adjusted accordingly for the de-risking so the flow of updated analyst reports will be interesting to read.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.